drugset / Trial / NCT01021215
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
RandomizedParallel-groupOpen-labelPrevention
Summary
The goal of this clinical research study is to learn how zileuton alone or the combination of zileuton and celecoxib may affect certain chemicals in the body that may be linked with a risk for smoking-related lung disease. These effects will be measured by a urine test
Timeline
- Start
- 2010-05
- Primary completion
- 2012-08
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 200 mg | Oral |
| Subject | Zileuton | Small molecule | 1200 mg | Oral |